You can buy or sell Danaher and other stocks, options, ETFs, and crypto commission-free!
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. Read More The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
Washington, District of Columbia
52 Week High
52 Week Low
Yahoo FinanceMar 18
Danaher to Gain From Solid Demand in Key Markets Amid Risks
On Mar 18, we issued an updated research report on Danaher Corporation DHR. In the past three months, this Zacks Rank #3 (Hold) stock has rallied 27.8% compared with the industry’s rise of 17.4%. Existing Scenario Danaher believes that higher demand for innovative products is likely to continue driving revenues in the upcoming quarters. In this regard, elevated demand for the company’s popular product lines — that include Biomek i Series, iCELLis bioreactor system, DxH 520 analyzer, DxA 5000 and Beckman ...
Present Change: Danaher Corporation (NYSE: DHR)
Danaher Corporation is part of the medical diagnostics and research industry and healthcare sector. The company CEO is Thomas P. Joyce. Danaher Corp designs, manufactures and markets professional, medical, industrial and commercial products and services. It markets its products under the brand of Beckman Coulter, Aperio, Dexis, Chemtreat and others. Previous Intraday Trading Performance: The DHR stock showed a previous change of 0.45% with an open at 128.19 and a close of 128.69. It reached an intraday hi...
Yahoo FinanceMar 12
See what the IHS Markit Score report has to say about Danaher Corp.
View full report here! Bearish sentiment Short interest | Positive Short interest is extremely low for DHR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting DHR. Money flow ETF/Index ownership | Neutral ETF activity is neutral. ETFs that hold DHR had net inflows of $4.17 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Econo...
Expected Apr 18, Pre-Market